Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Maintenance Therapy in Newly Diagnosed and Transplant Ineligible Multiple Myeloma Patients: A Meta-Analysis

Abdul Rafae, MD, Ali Jaan, MD, Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Sara Ashraf, MD, Sundas Ali, Sana Irfan Khan, MD, Israr Khan, Atif Irfan Khan, MD, Ahsan Wahab, MD, Rabia Ali, MBBS, Sara Saeed, MBBS, Mustafa Nadeem Malik, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-143287

Published: 2020

Journal Articles

Anti-Thymocyte Globulin (ATG) for Prophylaxis of Severe Graft Vs. Host Disease after Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis

Muhammad Ashar Ali, MD, Muhammad Yasir Anwar, Sobia Aamir, MDFCPS, Saad Ur Rahman, MBBS, Richi Kashyap, MD, Sana Irfan Khan, MD, Usman Ali Akbar, MBBS, Anum Waqar, MBBS, Anam Khan, Wajeeha Aiman, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-135950

Published: 2020

Journal Articles

Safety and Efficacy of Purine Analogs for Treatment of Waldenstrom Macroglobulinemia

Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Muhaddis Ejaz Ahmad, MD, Muhammad Ali Mirza, MD, Farhan Khalid, MBBS, Muhammad Tayyeb, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Sana Irfan Khan, MD, Richi Kashyap, MD, Saad Javed, MD, Unaiza Faizan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-138750

Published: 2020

Journal Articles

Safety and Efficacy of Anti-Bcma CAR-T Cells for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Literature

Israr Khan, Abdul Rafae, MD, Anum Javaid, MBBS, Zahoor Ahmed, MD, Haifza Abeera Qadeer, MBBS, Sana Irfan Khan, MD, Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Ali Jaan, MD, Farhan Khalid, MBBS, Zobia Aijaz, MBBS, Mydah Sajid Hashmi, MD, Mustafa Nadeem Malik, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-134529

Published: 2020

Journal Articles

Efficacy and Safety of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis

Sana Irfan Khan, MD, Muhammad Yasir Anwar, Abdul Rafae, MD, Anam Khan, Atif Irfan Khan, MD, Sobia Aamir, MDFCPS, Syeda Sabeeka Batool, MBBS, MD, Asim Tameez Ud Din, MD MBBS, Israr Khan, Anum Javaid, MD, Haifza Abeera Qadeer, MBBS, Zahoor Ahmed, MD, Rohail Gul, Zobia Aijaz, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-134986

Published: 2020

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Muhammad Salman Faisal, MD MBBS, Sana Irfan Khan, MD, Abdul Rafae, MD, Arshia Akbar, MDMBBS, Ahsan Wahab, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137141

Published: 2020

Journal Articles

COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients

Amardeep Kalsi, MD, Sana Irfan Khan, MD, Asad Rehman, Neil Nimkar, MD, Angelica Singh, MD, Nivetha Vishnuvardhan, MD, Sonal Paul, MD, Farah Ashraf, DO, Anita Mazloom, MD, Nisha Patel, MD, Rich Kodama, MD, Abeer Ashfaq, MD, Chathula Kumarasinghe, MD, Soeb Usta, MD, Peter Gregos, MD, Eshan Patel, MD, Uqba Khan, MD

Blood (2020) 136 (Supplement 1): 25.

https://doi.org/10.1182/blood-2020-142971

Published: 2020

Journal Articles

Efficacy and Safety of Voxelotor in Sickle Cell Disease: A Systematic Review

Muhammad Ashar Ali, MD, Anam Khan, Sana Irfan Khan, MD, Sobia Aamir, MDFCPS, Saad Ur Rahman, MBBS, Anum Waqar, MBBS, Hafsa Tahir Chaudry, MBBS, Muhammad Yasir Anwar, Wajeeha Aiman, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-135960

Published: 2020

Journal Articles

Efficacy and Safety of Blinatumomab for Relapsed or Refractory Pediatric ALL Patients: A Systematic Review

Anam Khan, Atif Irfan Khan, MD, Sana Irfan Khan, MD, Sobia Aamir, MDFCPS, Usman Ali Akbar, MBBS, Anum Waqar, MBBS, Muhammad Ashar Ali, MD, Abdul Jabbar Dar, MD, Richi Kashyap, MD, Saad Ur Rahman, MBBS, Muhammad Ali Mirza, MD, Qasim Khurshid, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-137576

Published: 2020

Journal Articles

CD-19 Specific CAR-T Cell Therapy in Relapsed/Refractory ALL in Pediatrics and Young Adults; Safety and Efficacy Outcomes: A Systematic Review and Meta-Analysis

Sobia Aamir, MDFCPS, Muhammad Ashar Ali, MD, Sana Irfan Khan, MD, Abdul Jabbar Dar, MD, Farhan Khalid, MBBS, Muhammad Yasir Anwar, Muhammad Tayyeb, MD, Anam Khan, Atif Irfan Khan, MD, Syeda Sabeeka Batool, MBBS, MD, Arshia Akbar, MDMBBS, Seemal Iftikhar, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-134059

Published: 2020

NARROW

Maintenance Therapy in Newly Diagnosed and Transplant Ineligible Multiple Myeloma Patients: A Meta-Analysis

Anti-Thymocyte Globulin (ATG) for Prophylaxis of Severe Graft Vs. Host Disease after Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis

Safety and Efficacy of Purine Analogs for Treatment of Waldenstrom Macroglobulinemia

Safety and Efficacy of Anti-Bcma CAR-T Cells for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Literature

Efficacy and Safety of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients

Efficacy and Safety of Voxelotor in Sickle Cell Disease: A Systematic Review

Efficacy and Safety of Blinatumomab for Relapsed or Refractory Pediatric ALL Patients: A Systematic Review

CD-19 Specific CAR-T Cell Therapy in Relapsed/Refractory ALL in Pediatrics and Young Adults; Safety and Efficacy Outcomes: A Systematic Review and Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only